window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-113618785-7');

AutoCRAT is a Horizon 2020 Project focused on:

  • delivering new cell and cell-based therapies for osteoarthritis (OA) and joint repair using sustainable sources of cells and

  • developing a closed, scalable and regulatory-compliant automated system to enable future production of therapeutic products.

Repairing Damage

Repairing Damage

AutoCRAT will explore using articular chondrocytes (cartilage cells) to help repair damage to joints.

Preventing & Treating OA

Preventing & Treating OA

AutoCRAT will explore using mesenchymal stromal cells (MSC) and extracellular vesicles (EVs) to prevent and to treat OA.

Generating Cells

Generating Cells

AutoCRAT will generate sustainable sources of cells ready for therapeutic use.

Automated Production

Automated Production

AutoCRAT will build a Regenerative Medicine Factory for cost-effective, controlled, automated manufacture of therapeutic products in line with regulations.

Find out more about the Project

The AutoCRAT Team

The AutoCRAT consortium is made up of the following partners:

Find out more about the Team here.

Latest News

Read all about our news, project updates and announcements on our news page.

Interview with Jelena Ochs, Fraunhofer Institute for Production Technology

June 4th, 2020|

Danielle Nicholson of Pintail Limited posed a few questions to Jelena Ochs of the Fraunhofer Institute for Production Technology (IPT) to gain her views on her work in automation research and development and AutoCRAT, in [...]

PARTNER NEWS: LUMC constructs the largest stem cell facility for the Netherlands and beyond

May 27th, 2020|

AutoCRAT partner Leiden University Medical Center (LUMC) will begin construction of the largest non-profit stem cell and gene therapy facility in the Netherlands in 2020. This will be one of the largest such facilities in [...]

Read more